M&A
Temple acquires longevity medicine practice Longevous
Delhi-based Temple, a healthtech company, has acquired London-based longevity medicine practice Longevous to enhance its clinical and scientific research capabilities. The acquisition involves the integration of Longevous founders Dr. Robert Mohr and Dr. Avi Roy into the team at Temple.Launched in 2025, Longevous produces longevity medicine integrating academic research, advanced diagnostics, and AI. Founded by Deepinder Goyal, Temple focuses on developing wearable technology designed to monitor physiological signals and longevity-related metrics. Following the acquisition, Dr. Mohr will serve as the Chief Medical Officer, and Dr. Roy will join as Head of Science. The company plans to utilize this new expertise to further the development of its proprietary "Entropy" metric, which calculates real-time energy expenditure, as it prepares for the product launch within the next year.
For FY25, Temple wearables had reported about INR 13 Cr in Net Loss.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
